Pancreatic Cancer Research

ResearcherWuhan Union HospitalActive in the last 2 years

Jianli Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9321-0837; OpenAlex author ID A5052936431. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study. Co-author DOI 10.1093/oncolo/oyae171↗
  2. Combined Antiangiogenic Therapy and Immunotherapy Is Effective for Pancreatic Cancer With Mismatch Repair Proficiency but High Tumor Mutation Burden: A Case Re… Last author DOI 10.1097/mpa.0000000000001398↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Xue · 1 shared paper, 2024 · strength 0.19
  2. Tao Zhang · 1 shared paper, 2024 · strength 0.19
  3. Min Jin · 1 shared paper, 2024 · strength 0.19
  4. Zhenyu Lin · 1 shared paper, 2024 · strength 0.19
  5. Hongli Liu · 1 shared paper, 2024 · strength 0.19
  6. Jian Hua Chang · 1 shared paper, 2019 · strength 0.11
  7. Mengni Chen · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.